Updated mid-term outlook: 2024-28 revenue CAGR of 5-7% with c.10% REBIT margin by 2028; and 2025 guidance: REBIT of at least ...

Of this equipment backlog stands €497 million for Proton Therapy, representing 37 projects and €247 million for other accelerators. So this backlog includes the revenues of our long-term ...

Specializing in the challenging and complicated concrete projects, Tarlton Concrete Group has found success by a skilled team ...

Louvain-la-Neuve, Belgium, March 24th, 2025 - Ion Beam Applications SA (IBA) announces today the launch of a share buyback ...

Read the entire full year 2024 results press release here Louvain-la-Neuve, Belgium, 20 March 2025 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announc ...

The company provides stereotactic radiosurgery equipment and advanced radiation ... despite challenges in leasing and proton therapy segments. Revenue increases 27% year over yearReports gain ...

Avista Healthcare Partners ("Avista"), a leading New York-based private equity firm focused exclusively on healthcare, is pleased to announce the successful completion of the sale of ...

This marks the third-largest order for RaySearch and introduces RayStation to Heyou Hospital's ion beam therapy equipment ...

TeamBest Global Companies logo - 2025 CRT Lifetime Achievement Award Brachytherapy Research & Educational Foundation (BREF) ...

Researchers Uncover Key Missing Link in Understanding Autoimmune DisordersAutoimmune diseases, which are estimated to affect ...